HLA-A, B, C Antigen Expression in Colorectal Carcinoma and Its Impact on Survival
Author Information
Author(s): B. Stein, F. Momburg, V. Schwarz, P. Schlag, G. Moldenhauer, P. Möller
Primary Institution: University of Heidelberg; German Cancer Research Center
Hypothesis
Does the expression of HLA-A, B, C antigens in colorectal carcinoma influence survival rates?
Conclusion
The presence or absence of MHC class I antigens does not significantly affect survival in colorectal carcinoma patients.
Supporting Evidence
- 68.6% of tumors expressed HLA-A, B, C antigens normally.
- 20.8% showed a substantial reduction in expression.
- 10% lacked these antigens completely or incompletely.
- Poor differentiation and mucus production were risk factors for survival.
Takeaway
This study looked at patients with colon cancer and found that whether or not their tumors had certain proteins didn't really change how long they lived.
Methodology
The study examined HLA-A, B, C antigen expression in tumor samples from 159 colorectal carcinoma patients and analyzed correlations with survival and differentiation.
Limitations
The study's findings may not apply to all types of colorectal cancer, and further research is needed with larger patient groups.
Participant Demographics
159 unselected patients, with a mean age of 66.3 years, including 91 males and 68 females.
Statistical Information
P-Value
0.0061
Statistical Significance
p=0.148
Want to read the original?
Access the complete publication on the publisher's website